The first in-human, phase 1, randomized, double-blind,
placebo-controlled study conducted to determine the safety,
tolerability, and pharmacokinetics of single and multiple ascending
oral doses of molnupiravir in healthy subjects.
About the Podcast
We bring you clinical summaries and critiques of the most trending medical literature on the market